Emerging Pharmaceutical Market in China - Forecast to Become The World’s Third-Largest Pharmaceutical Market By 2013

Published: September 2011
No. of Pages: 85
Price: $ 3500

GBI Research’s new report, “Emerging Pharmaceutical Market in China - Forecast to Become The World’s Third-Largest Pharmaceutical Market By 2013”, provides in-depth analysis of trends, issues and challenges in this industry. The report analyzes the effective strategies that shape the industry dynamics. Further, the report provides competitive benchmarking for the leading companies and analyzes the M&A and strategic partnerships that shape the Chinese pharmaceutical market. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts.

Scope

The scope of this report includes -

• Overall pharma, biotech and outsourcing market structure.

• Market characterization, including market size

• CMO & CRO market size and growth

• Key drivers and barriers that have a significant impact on the market.

• Competitive benchmarking of leading companies.

• Key M&A activities and strategic partnership deals that have taken place in 2009

Reasons to buy

The report will enhance your decision making capability. It will allow you to -

• Align your product portfolio to the markets with high growth potential.

• Develop market-entry and market expansion strategies by identifying the leading therapeutic segments poised for strong growth.

• Device a more tailored country strategy through the understanding of key drivers and barriers of the country’s pharmaceutical market.

• Develop key strategic initiatives by understanding the key focus areas of leading companies.

• Accelerate and strengthen your market position by identifying key companies for mergers, acquisitions and strategic partnerships.